Press Releases

The global imaging CRO market is growing rapidly at a CAGR of 7.1% during the forecast period 2025-2030. The rising number of clinical trials, development in the pharmaceutical industry, mounting awareness towards process automation, increased demand for high precision in drug manufacturing, and growing dependence of biotechnology and pharmaceutical companies on the CROs to conduct imaging trials will propel the growth of the global imaging CRO market. Several businesses in imaging CRO have undertaken substantial initiatives to build their position in the worldwide imaging CRO industry, where several players are fiercely battling for dominance. Despite the fact that they are currently trailing the industry leaders, some of these companies have made great progress toward becoming big players as a result of measures to extend their individual product portfolios and geographic reach. Nevertheless, the industry players are adopting strategies like a novel product launch, M&A to sustain their share and diversify the product portfolio.

In September 2023, the world's premier ophthalmology imaging core lab, Digital Angiography Reading Center (DARC), has been acquired by WorldCare Clinical (WCC), a worldwide imaging core lab situated in New York. Age-Related Macular Degeneration, Diabetic Retinopathy, Branch and Central Vein Occlusion, Choroidal Melanoma, Uveitis, PCV, and Retinitis Pigmentosa are just a few of the problems that DARC has studied.

During the first wave of the pandemic, most regions were under strict lockdown, and clinical trial operations that included imaging were deemed non-essential. With an increase in clinical studies, particularly for COVID-19, the market is predicted to normalize in the first half of 2021. During the pandemic, the number of clinical trials for COVID-19 treatment and vaccine development increased dramatically. In the coming years, the development of new vaccines and treatment regimens is projected to increase demand for imaging CRO.

Browse 53 market data Tables and 35 Figures spread through 200 Pages and in-depth TOC on " Imaging CRO Market by Service (Imaging Acquisition and Protocol Development, Application Design, Image Collection and QC, Digital Image Conversion, and Support and Maintenance), by Modality (Computed Tomography Scan, Magnetic Resonance Imaging (Diffusion Tensor Imaging, Functional MRI, Resting-State Functional Connectivity MRI, Volumetric MRI, and Arterial Spin Labeling for Quantitative Perfusion Imaging), Positron Emission Tomography (Positron Emission Tomography with 18F Isotope and Other PET), and Others), by Application (Oncology Imaging CRO, Ophthalmology Imaging CRO, Neurology Imaging CRO, Cardiology Imaging CRO, and Others), by End User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturers, Contract Research Organizations, Academic and Government Research Institutes, and Others), and Region - Global Forecast to 2030"

By end user, biotechnology and pharmaceutical companies is anticipated to have a significant growth during the forecast period.

The biotechnology and pharmaceutical companies are anticipated to have significant growth owing to the rising demand for developing novel drugs and therapies to cure chronic and severe diseases.   As biotechnology and pharmaceutical companies continue to make ground-breaking drug discoveries, the demand for clinical trial imaging will rise, resulting in the growth of imaging CRO.

Global Imaging CRO Market Segmentation and Key Players

Discover More About This Report, Download A Free Sample Copy of Global Imaging CRO Market

“North America is anticipated to have a high CAGR during the forecast period 2025-2030.”

The imaging CROs is anticipated to grow at a high CAGR in the North American region owing to support from the government regarding favorable regulations and programs that will accelerate the growth. Additionally, the other major factor, which is the presence of major players such as Parexel International, Imaging Endpoints, etc. offers accessibility of clinical trial imaging services, resulting in propelling the growth of the imaging CRO market in the region.

Some of the major players in the global Imaging CRO market include Parexel International Corporation, WORLDCARE CLINICAL, ICON plc, IXICO plc, The Micron Group, WuXi AppTec, Medpace, Labcorp Drug Development, Imaging Endpoints, and Radiant Sage LLC.

Global Imaging CRO Market Coverage

Service Insight and Forecast 2025-2030

• Imaging Acquisition and Protocol Development
• Application Design
• Image Collection and QC
• Digital Image Conversion
• Support and Maintenance

Modality Insight and Forecast 2025-2030

• Computed Tomography Scan
• Magnetic Resonance Imaging
  • Diffusion Tensor Imaging
  • Functional MRI
  • Resting-State Functional Connectivity MRI
  • Volumetric MRI
  • Arterial Spin Labeling for Quantitative Perfusion Imaging
• Positron Emission Tomography
  • Positron Emission Tomography with 18F Isotope
  • Other PET
• Others

Application Insight and Forecast 2025-2030

• Oncology Imaging CRO
• Ophthalmology Imaging CRO
• Neurology Imaging CRO
• Cardiology Imaging CRO
• Others

End User Insight and Forecast 2025-2030

• Pharmaceutical Companies
• Biotechnology Companies
• Medical Device Manufacturers
• Contract Research Organizations
• Academic and Government Research Institutes
• Others

Geographical Segmentation

Imaging CRO Market by Region

North America

• By Service
• By Modality
• By Application
• By End User
• By Country – U.S., Canada, and Mexico

Europe

• By Service
• By Modality
• By Application
• By End User
• By Country – Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe

Asia-Pacific (APAC)

• By Service
• By Modality
• By Application
• By End User
• By Country – China, Japan, India, South Korea, and Rest of Asia-Pacific

Rest of the World (RoW)

• By Service
• By Modality
• By Application
• By End User
• By Country – Brazil, Saudi Arabia, South Africa, U.A.E., and Other Countries